PortfoliosLab logoPortfoliosLab logo
WDNA vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WDNA vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


WDNA

1D
2.94%
1M
2.56%
YTD
8.96%
6M
10.44%
1Y
50.50%
3Y*
3.54%
5Y*
-4.78%
10Y*

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WDNA vs. GERM - Yearly Performance Comparison


2026 (YTD)20252024
WDNA
WisdomTree BioRevolution Fund
8.96%22.68%-10.00%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%

WDNA vs. GERM - Sectors Allocation Comparison


Sectors
WDNA
GERM

Healthcare

85.0%
99.3%

Basic Materials

6.5%

-

Consumer Defensive

3.0%

-

Energy

1.1%

-

Communication Services

-

-

Consumer Cyclical

-

-

Financial Services

-

0.4%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

WDNA
85.0%
GERM
99.3%

Basic Materials

WDNA
6.5%
GERM

-

Consumer Defensive

WDNA
3.0%
GERM

-

Energy

WDNA
1.1%
GERM

-

Communication Services

WDNA

-

GERM

-

Consumer Cyclical

WDNA

-

GERM

-

Financial Services

WDNA

-

GERM
0.4%

Industrials

WDNA

-

GERM

-

Real Estate

WDNA

-

GERM

-

Technology

WDNA

-

GERM

-

Utilities

WDNA

-

GERM

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WDNA vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDNA
WDNA Risk / Return Rank: 6363
Overall Rank
WDNA Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
WDNA Sortino Ratio Rank: 6262
Sortino Ratio Rank
WDNA Omega Ratio Rank: 5353
Omega Ratio Rank
WDNA Calmar Ratio Rank: 8383
Calmar Ratio Rank
WDNA Martin Ratio Rank: 5757
Martin Ratio Rank

GERM
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDNA vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WDNAGERMDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.32

Calmar ratioReturn relative to maximum drawdown

4.34

Martin ratioReturn relative to average drawdown

9.85

WDNA vs. GERM - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


WDNAGERMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.98

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.19

Drawdowns

WDNA vs. GERM - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for WDNA and GERM.


Loading charts...

Drawdown Indicators


WDNAGERMDifference

Max Drawdown

Largest peak-to-trough decline

-58.87%

0.00%

-58.87%

Max Drawdown (1Y)

Largest decline over 1 year

-11.70%

0.00%

-11.70%

Max Drawdown (3Y)

Largest decline over 3 years

-38.25%

Max Drawdown (5Y)

Largest decline over 5 years

-58.87%

Current Drawdown

Current decline from peak

-29.86%

0.00%

-29.86%

Average Drawdown

Average peak-to-trough decline

-35.64%

0.00%

-35.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.14%

0.00%

+5.14%

Volatility

WDNA vs. GERM - Volatility Comparison

WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 7.35% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WDNAGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.35%

0.00%

+7.35%

Volatility (6M)

Calculated over the trailing 6-month period

16.59%

0.00%

+16.59%

Volatility (1Y)

Calculated over the trailing 1-year period

25.66%

0.00%

+25.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.08%

0.00%

+25.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.07%

0.00%

+25.07%

WDNA vs. GERM - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is lower than GERM's 0.68% expense ratio.


Dividends

WDNA vs. GERM - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 4.19%, while GERM has not paid dividends to shareholders.


PositionTTM20252024202320222021
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%
WDNA
WisdomTree BioRevolution Fund
4.19%4.57%0.75%0.80%0.38%0.10%

Frequently Asked Questions


WDNA has higher volatility (7.35%) compared to GERM (0.00%). In terms of maximum drawdown, WDNA dropped -58.87% vs GERM's 0.00%.

On 1-year performance, WDNA leads with 50.50% vs 0.00% for GERM. On fees, WDNA is cheaper at 0.45% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, WDNA has performed better with a 50.50% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

WDNA is cheaper with a 0.45% expense ratio, compared with 0.68% for GERM.

WDNA has the higher dividend yield at 4.19%, compared with 0.00% for GERM.

WDNA tracks WisdomTree BioRevolution Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: WisdomTree and Amplify. Their fees differ too: 0.45% for WDNA and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for WDNA and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer